by Alison Bass | Jun 14, 2011 | pharmaceutical industry, Uncategorized, university industry collaboration
I was planning to blog about Pfizer’s new $100 million partnership with several Boston-area medical centers and its potential downsides. But before I could get around to doing that, I was invited to talk about the deal on WGBH-TV’s Greater Boston show...
by Alison Bass | May 3, 2011 | Uncategorized
Stan Kutcher, the psychiatrist turned politician who threatened to sue The Coast newspaper in Halifax unless it issued a retraction on a story it did about Kutcher’s involvement with Paxil study 329 (see retracted story here) and my blog about it), lost...
by Alison Bass | May 1, 2011 | Uncategorized
In recent years, experts (like Bill Kovach and Tom Rosenstiel) have warned that press freedoms are under increasing threat from economic pressures. As advertising and readers flee to the Web, they say, news outlets are more likely to cave in to pressure from corporate...
by Alison Bass | Apr 25, 2011 | Uncategorized
In 2006, researchers first published results from a $35 million NIMH-funded study of antidepressants known as STAR*D, claiming it proved the effectiveness of second-generation antidepressants used alone and in combination with each other. The NIMH chimed in with press...
by Alison Bass | Apr 15, 2011 | Uncategorized
Medicaid and Medicare are in the news of late, as Congressional Republicans spar with President Obama and the Democrats on how best to rein in the ballooning costs of these entitlement programs, which make up a growing share of federal and state budgets. But what few...
by Alison Bass | Apr 4, 2011 | Uncategorized
Psychiatry is supposed to be all about disclosure, disclosing the dark secrets of one’s past to a professional in an effort to heal or, at the very least, figure out why one is in such psychic pain. But given the recent actions of the American Psychiatric...
